Show source-provided references
2. Almonte-Becerril, M., Gimeno, L.I., Villarroya, O., Benito-Jardon, M., Kouri, J.B., and Costell, M. (2018). Genetic abrogation of the fibronectin-alpha5beta1 integrin interaction in articular cartilage aggravates osteoarthritis in mice. PLoS ONE, 13.
10.1371/journal.pone.0198559 ↗4. Roseti, L., Desando, G., Cavallo, C., Petretta, M., and Grigolo, B. (2019). Articular Cartilage Regeneration in Osteoarthritis. Cells, 8.
10.3390/cells8111305 ↗5. Lindler, B.N., Long, K.E., Taylor, N.A., and Lei, W. (2020). Use of Herbal Medications for Treatment of Osteoarthritis and Rheumatoid Arthritis. Medicines, 7.
10.3390/medicines7110067 ↗7. Microfracture versus Drilling of Articular Cartilage Defects: A Systematic Review of the Basic Science Evidence
10.1177/2325967120945313 ↗8. Application of mesenchymal stem cell therapy for the treatment of osteoarthritis of the knee: A concise review
10.4252/wjsc.v11.i4.222 ↗11. New Insights into Cartilage Tissue Engineering: Improvement of Tissue-Scaffold Integration to Enhance Cartilage Regeneration
10.1155/2022/7638245 ↗12. Effect of self-assembled peptide-mesenchymal stem cell complex on the progression of osteoarthritis in a rat model
10.2147/IJN.S54114 ↗13. Human adipose-derived mesenchymal stem cells for osteoarthritis: A pilot study with long-term follow-up and repeated injections
10.2217/rme-2017-0152 ↗14. 3D in-vitro cultures of human bone marrow and Wharton’s jelly derived mesenchymal stromal cells show high chondrogenic potential
10.3389/fbioe.2022.986310 ↗15. Mesenchymal stem cells in osteoarthritis therapy: A review
16. Mazini, L., Rochette, L., Amine, M., and Malka, G. (2019). Regenerative Capacity of Adipose Derived Stem Cells (ADSCs), Comparison with Mesenchymal Stem Cells (MSCs). Int. J. Mol. Sci., 20.
10.3390/ijms20102523 ↗17. Clinical Application Status of Articular Cartilage Regeneration Techniques: Tissue-Engineered Cartilage Brings New Hope
10.1155/2020/5690252 ↗18. Immunomodulatory and Regenerative Effects of Mesenchymal Stem Cells and Extracellular Vesicles: Therapeutic Outlook for Inflammatory and Degenerative Diseases
10.3389/fimmu.2020.591065 ↗19. Cheng, J., Sun, Y., Ma, Y., Ao, Y., Hu, X., and Meng, Q. (2022). Engineering of MSC-Derived Exosomes: A Promising Cell-Free Therapy for Osteoarthritis. Membranes, 12.
10.3390/membranes12080739 ↗20. Exosomes derived from human umbilical cord blood mesenchymal stem cells stimulate regenerative wound healing via transforming growth factor-beta receptor inhibition
10.1186/s13287-021-02517-0 ↗21. Anti-inflammatory and immunomodulatory effects of the extracellular vesicles derived from human umbilical cord mesenchymal stem cells on osteoarthritis via M2 macrophages
10.1186/s12951-021-01236-1 ↗22. MicroRNA in osteoarthritis: Physiopathology, diagnosis and therapeutic challenge
10.1093/bmb/ldz015 ↗23. Porcine Platelet Lysate Intra-articular Knee Joint Injections for the Treatment of Rabbit Cartilage Lesions and Osteoarthritis
10.1007/s40846-023-00776-1 ↗25. Mesenchymal Stem Cell-Derived Extracellular Vesicles Therapy for Pulmonary Hypertension: A Comprehensive Review of Preclinical Studies
10.1155/2022/5451947 ↗26. Zhang, B., Tian, X., Qu, Z., Hao, J., and Zhang, W. (2022). Hypoxia-Preconditioned Extracellular Vesicles from Mesenchymal Stem Cells Improve Cartilage Repair in Osteoarthritis. Membranes, 12.
10.3390/membranes12020225 ↗29. Tropoelastin improves adhesion and migration of intra-articular injected infrapatellar fat pad MSCs and reduces osteoarthritis progression
10.1016/j.bioactmat.2021.09.011 ↗31. The OARSI histopathology initiative—Recommendations for histological assessments of osteoarthritis in the rat
10.1016/j.joca.2010.05.030 ↗32. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data
10.2106/00004623-197153030-00009 ↗34. miR-100-5p-abundant exosomes derived from infrapatellar fat pad MSCs protect articular cartilage and ameliorate gait abnormalities via inhibition of mTOR in osteoarthritis
10.1016/j.biomaterials.2019.03.022 ↗35. Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: Review of current clinical trials
10.1186/s12929-016-0289-5 ↗36. Effects of donor age, gender, and in vitro cellular aging on the phenotypic, functional, and molecular characteristics of mouse bone marrow-derived mesenchymal stem cells
10.1089/scd.2010.0280 ↗37. Umbilical Cord-Derived Mesenchymal Stem Cell-Derived Exosomal MicroRNAs Suppress Myofibroblast Differentiation by Inhibiting the Transforming Growth Factor-beta/SMAD2 Pathway During Wound Healing
10.5966/sctm.2015-0367 ↗38. Intra-Articular Injections of Mesenchymal Stem Cell Exosomes and Hyaluronic Acid Improve Structural and Mechanical Properties of Repaired Cartilage in a Rabbit Model
10.1016/j.arthro.2020.03.031 ↗39. Bone marrow mesenchymal stem cell-derived exosomes protect cartilage damage and relieve knee osteoarthritis pain in a rat model of osteoarthritis
10.1186/s13287-020-01781-w ↗41. Exosomes derived from mesenchymal stem cells inhibit mitochondrial dysfunction-induced apoptosis of chondrocytes via p38, ERK, and Akt pathways
10.1007/s11626-019-00330-x ↗42. Degeneration of the lumbar spine and its relation to the expression of collagen and elastin in facet joint capsules and ligament flavum
10.5152/j.aott.2022.21314 ↗44. LncRNA-p21 promotes chondrocyte apoptosis in osteoarthritis by acting as a sponge for miR-451